Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Allison B Rosen MD, MPH, SCD

    TitleAssociate Professor
    InstitutionUniversity of Massachusetts Medical School
    DepartmentQuantitative Health Sciences
    AddressUniversity of Massachusetts Medical School
    55 Lake Avenue North
    Worcester MA 01655
      Other Positions
      InstitutionUMMS - School of Medicine
      DepartmentMedicine

      InstitutionUMMS - Graduate School of Biomedical Sciences
      DepartmentClinical Population Health Research

        Overview 
        Narrative

        Education

        Sc.D., Health Policy and Management, Harvard School of Public Health, 2004
        M.D., Duke University School of Medicine, 1999
        M.P.H., University of North Carolina, Chapel Hill, 1998
        B.S., Economics, The Wharton School, University of Pennsylvania, 1992

        Dr. Rosen's current work focuses on how best to measure and improve the valueof U.S. health care spending, with a particular focus on the feasibility and effectiveness of linking medical coverage to value. Much of her researchrelates to the care of people with chronic illnesses, particularly diabetesand cardiovascular disease, and how to increase the use of effective butunderutilized therapies.

        Select current research includes:

        1.Evaluation of prospective interventions of targeted value-based copayment reductions for highly cost-effective but underutilized therapies (e.g. medications, eye exams) in large employers' covered populations with chronic diseases.

        2. Development of a revised set of national health accounts (adding a measure of population health alongside spending) to better understand the returns to U.S. health care spending.



        Bibliographic 
        selected publications
        List All   |   Timeline
        1. Rosen AB, Aizcorbe A, Ryu AJ, Nestoriak N, Cutler DM, Chernew ME. Policy makers will need a way to update bundled payments that reflects highly skewed spending growth of various care episodes. Health Aff (Millwood). 2013 May; 32(5):944-51.
          View in: PubMed
        2. Pirraglia PA, Hampton JM, Rosen AB, Witt WP. Psychological distress and trends in healthcare expenditures and outpatient healthcare. Am J Manag Care. 2011 May; 17(5):319-28.
          View in: PubMed
        3. Fang MC, Cutler DM, Rosen AB. Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med. 2010 Sep; 5(7):406-9.
          View in: PubMed
        4. Greenberg D, Rosen AB, Wacht O, Palmer J, Neumann PJ. A bibliometric review of cost-effectiveness analyses in the economic and medical literature: 1976-2006. Med Decis Making. 2010 May-Jun; 30(3):320-7.
          View in: PubMed
        5. Heisler M, Choi H, Rosen AB, Vijan S, Kabeto M, Langa KM, Piette JD. Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Med Care. 2010 Feb; 48(2):87-94.
          View in: PubMed
        6. Chernew ME, Juster IA, Shah M, Wegh A, Rosenberg S, Rosen AB, Sokol MC, Yu-Isenberg K, Fendrick AM. Evidence that value-based insurance can be effective. Health Aff (Millwood). 2010 Mar-Apr; 29(3):530-6.
          View in: PubMed
        7. Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med. 2009 Dec 3; 361(23):2252-60.
          View in: PubMed
        8. Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA. 2009 Oct 14; 302(14):1573-9.
          View in: PubMed
        9. Rosen AB, Spaulding AB, Greenberg D, Palmer JA, Neumann PJ. Patient adherence: a blind spot in cost-effectiveness analyses? Am J Manag Care. 2009 Sep; 15(9):626-32.
          View in: PubMed
        10. Rosen AB, Cutler DM. Challenges in building disease-based national health accounts. Med Care. 2009 Jul; 47(7 Suppl 1):S7-13.
          View in: PubMed
        11. Spaulding A, Fendrick AM, Herman WH, Stevenson JG, Smith DG, Chernew ME, Parsons DM, Bruhnsen K, Rosen AB. A controlled trial of value-based insurance design - the MHealthy: Focus on Diabetes (FOD) trial. Implement Sci. 2009; 4:19.
          View in: PubMed
        12. Stewart ST, Woodward RM, Rosen AB, Cutler DM. The impact of symptoms and impairments on overall health in US national health data. Med Care. 2008 Sep; 46(9):954-62.
          View in: PubMed
        13. Chernew M, Gibson TB, Yu-Isenberg K, Sokol MC, Rosen AB, Fendrick AM. Effects of increased patient cost sharing on socioeconomic disparities in health care. J Gen Intern Med. 2008 Aug; 23(8):1131-6.
          View in: PubMed
        14. Chernew ME, Shah MR, Wegh A, Rosenberg SN, Juster IA, Rosen AB, Fendrick AM. Confronting hysteria: a reply to Fairman and Curtiss. J Manag Care Pharm. 2008 Apr; 14(3):324-6; author reply 326-8.
          View in: PubMed
        15. Langa KM, Larson EB, Karlawish JH, Cutler DM, Kabeto MU, Kim SY, Rosen AB. Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity? Alzheimers Dement. 2008 Mar; 4(2):134-44.
          View in: PubMed
        16. Chernew ME, Shah MR, Wegh A, Rosenberg SN, Juster IA, Rosen AB, Sokol MC, Yu-Isenberg K, Fendrick AM. Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff (Millwood). 2008 Jan-Feb; 27(1):103-12.
          View in: PubMed
        17. Braithwaite RS, Rosen AB. Linking cost sharing to value: an unrivaled yet unrealized public health opportunity. Ann Intern Med. 2007 Apr 17; 146(8):602-5.
          View in: PubMed
        18. Brauer CA, Neumann PJ, Rosen AB. Trends in cost effectiveness analyses in orthopaedic surgery. Clin Orthop Relat Res. 2007 Apr; 457:42-8.
          View in: PubMed
        19. Chernew ME, Rosen AB, Fendrick AM. Value-based insurance design. Health Aff (Millwood). 2007 Mar-Apr; 26(2):w195-203.
          View in: PubMed
        20. Rosen AB, Cutler DM, Norton DM, Hu HM, Vijan S. The value of coronary heart disease care for the elderly: 1987-2002. Health Aff (Millwood). 2007 Jan-Feb; 26(1):111-23.
          View in: PubMed
        21. Cutler DM, Rosen AB, Vijan S. The value of medical spending in the United States, 1960-2000. N Engl J Med. 2006 Aug 31; 355(9):920-7.
          View in: PubMed
        22. Brauer CA, Rosen AB, Greenberg D, Neumann PJ. Trends in the measurement of health utilities in published cost-utility analyses. Value Health. 2006 Jul-Aug; 9(4):213-8.
          View in: PubMed
        23. Rosen AB. Grounding coverage in value: a paradigm for linking quality and costs. Med Care. 2006 May; 44(5):389-91.
          View in: PubMed
        24. Rosen AB. Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002. J Gen Intern Med. 2006 Apr; 21(4):315-9.
          View in: PubMed
        25. Chernew ME, Rosen AB, Fendrick AM. Rising out-of-pocket costs in disease management programs. Am J Manag Care. 2006 Mar; 12(3):150-4.
          View in: PubMed
        26. Bell CM, Urbach DR, Ray JG, Bayoumi A, Rosen AB, Greenberg D, Neumann PJ. Bias in published cost effectiveness studies: systematic review. BMJ. 2006 Mar 25; 332(7543):699-703.
          View in: PubMed
        27. Neumann PJ, Lin PJ, Greenberg D, Berger M, Teutsch S, Mansley E, Weinstein MC, Rosen AB. Do drug formulary policies reflect evidence of value? Am J Manag Care. 2006 Jan; 12(1):30-6.
          View in: PubMed
        28. Neumann PJ, Rosen AB, Weinstein MC. Medicare and cost-effectiveness analysis. N Engl J Med. 2005 Oct 6; 353(14):1516-22.
          View in: PubMed
        29. Rosen AB, Hamel MB, Weinstein MC, Cutler DM, Fendrick AM, Vijan S. Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes. Ann Intern Med. 2005 Jul 19; 143(2):89-99.
          View in: PubMed
        30. Neumann PJ, Rosen AB, Greenberg D, Olchanski NV, Pande R, Chapman RH, Stone PW, Ondategui-Parra S, Nadai J, Siegel JE, Weinstein MC. Can we better prioritize resources for cost-utility research? Med Decis Making. 2005 Jul-Aug; 25(4):429-36.
          View in: PubMed
        31. Rosen AB, Greenberg D, Stone PW, Olchanski NV, Neumann PJ. Quality of abstracts of papers reporting original cost-effectiveness analyses. Med Decis Making. 2005 Jul-Aug; 25(4):424-8.
          View in: PubMed
        32. Stone PW, Schackman BR, Neukermans CP, Olchanski N, Greenberg D, Rosen AB, Neumann PJ. A synthesis of cost-utility analysis literature in infectious disease. Lancet Infect Dis. 2005 Jun; 5(6):383-91.
          View in: PubMed
        33. Brauer CA, Rosen AB, Olchanski NV, Neumann PJ. Cost-utility analyses in orthopaedic surgery. J Bone Joint Surg Am. 2005 Jun; 87(6):1253-9.
          View in: PubMed
        34. Rosen AB, Blendon RJ, DesRoches CM, Benson JM, Bates DW, Brodie M, Altman DE, Zapert K, Steffenson AE, Schneider EC. Physicians' views of interventions to reduce medical errors: does evidence of effectiveness matter? Acad Med. 2005 Feb; 80(2):189-92.
          View in: PubMed
        35. Neumann PJ, Greenberg D, Olchanski NV, Stone PW, Rosen AB. Growth and quality of the cost-utility literature, 1976-2001. Value Health. 2005 Jan-Feb; 8(1):3-9.
          View in: PubMed
        36. Sonnad SS, Greenberg D, Rosen AB, Neumann PJ. Diffusion of published cost-utility analyses in the field of health policy and practice. Int J Technol Assess Health Care. 2005; 21(3):399-402.
          View in: PubMed
        37. Pirraglia PA, Rosen AB, Hermann RC, Olchanski NV, Neumann P. Cost-utility analysis studies of depression management: a systematic review. Am J Psychiatry. 2004 Dec; 161(12):2155-62.
          View in: PubMed
        38. Rosen AB, Karter AJ, Liu JY, Selby JV, Schneider EC. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Intern Med. 2004 Jun; 19(6):669-75.
          View in: PubMed
        39. Greenberg D, Rosen AB, Olchanski NV, Stone PW, Nadai J, Neumann PJ. Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysis. BMJ. 2004 Jun 26; 328(7455):1536-7.
          View in: PubMed
        40. Rosen AB, Schneider EC. Colorectal cancer screening disparities related to obesity and gender. J Gen Intern Med. 2004 Apr; 19(4):332-8.
          View in: PubMed
        41. Fanikos J, Tsilimingras K, Kucher N, Rosen AB, Hieblinger MD, Goldhaber SZ. Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Am J Cardiol. 2004 Jan 15; 93(2):247-50.
          View in: PubMed
        42. Rosen AB, Tsai JS, Downs SM. Variations in risk attitude across race, gender, and education. Med Decis Making. 2003 Nov-Dec; 23(6):511-7.
          View in: PubMed
        43. Blendon RJ, DesRoches CM, Brodie M, Benson JM, Rosen AB, Schneider E, Altman DE, Zapert K, Herrmann MJ, Steffenson AE. Views of practicing physicians and the public on medical errors. N Engl J Med. 2002 Dec 12; 347(24):1933-40.
          View in: PubMed
        For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
        Allison's Networks
        Click the "See All" links for more information and interactive visualizations!
        Concepts
        _
        Similar People
        _
        Same Department
        Physical Neighbors
        _

        This is an official Page/Publication of the University of Massachusetts Worcester Campus
        Office of the Vice Provost for Research, 55 Lake Ave North, Worcester, Massachusetts 01655
        Questions or Comments? Email: publicaffairs@umassmed.edu Phone: 508-856-1572